chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Increased blood pressure; Pain breathing; felt some discomfort in her hand; This is a spontaneous report from a contactable Physician.     A 82-years-old female patient received the first dose of  bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on  08Feb2021 at 0.3 mL, single for Covid-19 immunisation .  Medical history included ongoing cardiac disorder (she has had five bypasses ten years ago) , ongoing lung disorder,  ongoing osteoporosis  , she has had three operations on her spinal cord. She has a neurologic compression fracture from ages ago , seasonal allergy,  nitrate compound therapy, hypertension, anticoagulant therapy, electrolyte imbalance.  Concomitant medication included ranolazine (RANEXA), isosorbide (ISOSORBIDE), gliclazide (DIAZIDE [GLICLAZIDE]), apixaban (ELIQUIS), magnesium (MAGNESIUM) , ubidecarenone (Q-10 CO-ENZYME).  The patient experienced increased blood pressure  on 09Feb2021 with outcome of not recovered , pain breathing  on 09Feb2021 with outcome of not recovered , felt some discomfort in her hand  on 09Feb2021 with outcome of unknown.  The patient underwent lab tests and procedures which included blood pressure measurement: increased   on 09Feb2021 166/100 and pulse 65. The 100 was alarming to her. The patient would notice the increase in blood pressure and pain breathing when walking longer distances  Information on the lot/ batch number has been requested.
My right eye,lips and face had discomfort; My right eye,lips and face had discomfort; My right eye,lips and face had discomfort; I felt malaise for the rest of that day; right sided discomfort; This is a spontaneous report from a contactable nurse (patient). This 38-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EK9231) via an unspecified route of administration on 21Jan2021 at 14:00 (at the age of 38-years-old) as a single dose in the right arm for COVID-19 immunization. The patient did not have any medical history. The patient was not pregnant at the time of vaccination. Prior to the vaccine, the patient was not diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. The patient reported taking unspecified concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On 21Jan2021 at 14:30 the patient experienced right sided discomfort. Her right eye, lips, and face had discomfort; not pain but a strange feeling. The patient also felt malaise for the rest of that day (21Jan2021) and the following day. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcome of right sided discomfort, right eye, lips, and face discomfort, and malaise was recovered. It was also reported that since the vaccination the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Fever, chills, body aches, headache, Fatigue, several days, now resolved
Information has been received from a male physician reporting on himself with drug hypersensitivity to BENICAR and no pertinent medical history who on 22-NOV-2011, was vaccinated with a dose of ZOSTAVAX (Merck) (lot number, dose and route not reported). Concomitant therapy included losartan potassium (manufacturer unspecified), TOPROL XL tablets, ALDACTAZIDE and baby aspirin. The physician reported that on 30-NOV-2011, he had experienced vertigo and hearing loss in his right ear after receiving a dose of the vaccine. The physician sought unspecified medical attention. Prednisone (manufacturer unspecified) and FAMVIR were given as treatment for the events. An audiogram was performed (results not provided). At the time of the report the patient was recovering from vertigo and hearing loss in his right ear. Upon internal review, hearing loss was determined to be an other important medical event. Additional information has been requested.
Report A0363116A describes memory loss in a 53 pt who rec'd Lyme disease vaccine recombinant OspA (LYMErix). This report was rec'd as part of litigation proceedings, with forwarding of medical records. Medical history included Lyme disease (1985), mild hypalgesia in the left ulnar nerve territory of L hand (1987), nephrolithiasis, plantar fasciitis, rectal polypectomy (1996), herpes simple II virus with occasional recurrence, rheumatic fever with subsequent trace mitral/aortic/tricuspid regurgitation (11996), possible mitral valve prolapse, possible history of measles, mononucleosis, cervical strain with left radiculopathy and headaches due to MVA (1985). Other medical history has nothing to do with adverse events from the vaccine. In 4/99, the pt rec'd his 1st injection of LYMErix. Subsequently, he experienced chills and myalgia. These adverse events resolved. In 5/99, and 3/00, the pt rec'd his 2nd and 3rd injection of LYMErix, respectively. In a statement of injuries,the pt's attorney alleged that the pt suffers from pain in his joints as swell as flu-like symptoms and fatigue. He also experiences headaches and memory loss. On 5/19/99, the pt was seen by his physician. The pt related during the case history that he had experienced head and neck pain, headaches, neck stiffness, pain between the shoulders, numbness, and arm pain since his MVA on 6/18/98. He denied these symptoms prior to his MVA. His current complaints were neck pain, neck stiffness and L arm pain. Initially these were rated a ten on a zero to ten scale with ten being excruciating pain and zero no pain at all. Currently, he rated his pain a four. In 3/00 the physician stated that "I cannot make a specific diagnosis. His history of morning stiffness lasting several hrs is disconcerting, but given his excellent examination and relatively normal blood work a specific diagnosis cannot be made... Whether or not his symptoms are related to his Lyme vaccine is difficult to say.. He does not show any signs of an inflammatory arthropathy on examination today.
experienced gastrointestinal issues, diarrhea; experienced gastrointestinal issues, diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (experienced gastrointestinal issues, diarrhea) and DIARRHOEA (experienced gastrointestinal issues, diarrhea) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (experienced gastrointestinal issues, diarrhea) and DIARRHOEA (experienced gastrointestinal issues, diarrhea). At the time of the report, ABDOMINAL DISCOMFORT (experienced gastrointestinal issues, diarrhea) and DIARRHOEA (experienced gastrointestinal issues, diarrhea) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received as non-significant information where consent to follow-up is denied.
Received flu and pneumovax on 11/18/02. At approximately 11PM on 11/18/02, began to feel achy, back hurt, sweating, ribs hurt, swelling in abdomen. ER on 11/19/02. Advised rest, Tylenol. CXR and labs done.
Rapid heart rate, chest feels heavy, shortness of breath, dizziness, still fatigued after 4 days, I have to take deep breaths to feel like I?m getting enough air
I got my booster shot on 10/28/2021 and my adverse evet started on 11/02/2021. 10/28/2021 sore arm, tired, same thing on the 10/29/2021. When I woke up in the morning of 11/02/2021 I had breathing problem with my nose and lungs. I was experiencing with upper respiratory issues. I started seeing my doctors to see what was going on. They gave me inhalers, nasal rinses. I was sent to several specialists such as pulmonary, allergists, pulmonologist. My breathing issue decreased little after all the medications but I still have them. I still have breathing issue. I also went to an ENT. I have problems with nasal and lungs still now.
the first 2 days , my arm was very sore, then I took some IBprofin and the pain subsided. On the 2nd day I noticed a lump, located on my clavicle, between my bra strap & the base of my neck. It will roll around when pressed with my fingers.    after 5 days, it has gotten smaller.
This spontaneous report was received from a other nurse, concerning a 12 month old patient.  There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 21-MAR-2018, the patient was vaccinated with VARIVAX lot # M012990 and expiration date of 14-MAR-2018, (route of administration and anatomical location were not reported) for prophylaxis. The vaccine was reocnstituted with properly stored sterile diluent(MERCK STERILE DILUENT). Expired VARIVAX had no temperature excursions prior to being administered. No adverse effects were reported.
2nd day - had terrible headache the entire day, sore arm for a couple days.  Day 8 going into day 9 at 2am, woke up due to severe pain in injection site, site warm to touch, slight redness and very tender with knot
Elevated liver enzymes; This case was reported by a physician via call center representative and described the occurrence of elevated liver enzymes in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd June 2020, the patient received Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced elevated liver enzymes. On an unknown date, the outcome of the elevated liver enzymes was unknown.   It was unknown if the reporter considered the elevated liver enzymes to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group of the patient was not reported, but selected as an adult as per vaccine indication. The reporter stated that, the patient received Shingrix vaccine 2 weeks from the date of reporting of adverse event. No other information were provided. The reporter did not consent to follow up.
Persistent diarrhea began about April 20. Visited family doctor who referred me to GI doctor for colonoscopy. Colonoscopy performed on June 28, 2021. Histology indicated lymphotytic colitis. Successfully treated with budesonide.
Left pontine stroke with right hemiparesis. Treated and discharged. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
60 y/o female presented on 2/25/22 with pain, redness and mild swelling radiating form the injection site approximately 6 inches down left arm. Redness was warm and sensitive to the touch. Pt started benedryl and tylenol. Reported reduced pain on 2/26 with continued redness. Reported reduced pain and redness on 2/27.  Will continue to follow up with patient
on 12/30/20 at around 4:45 pm experienced tachycardia and palpitations heart rate went up to 160, on 1/4/20 at around 9:30 am rash started on face
Mom called to report symptoms. Arrived at clinic examined injection site by RN. Left deltoid and arm red, swollen, tender. Mom reports fever 100.3 F, nausea, HA evening of injections 6/26/07. In a.m. 6/27/07 arm (L) swollen and red called and brought son to clinic 6/28/07 p.m. Child given Tylenol every 4 hours as needed.
Significant soreness in arm, pain ,stiffness, Went to see her physician, presented with a raised patch at injection site that was painful & warm to the touch. Physician believed the patient had cellulitis and prescribed antibiotics for 7 days as well as prn Benadryl for the inflammation
This spontaneous report as received from a nurse via pother company letter (Pfizer) refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX23. The reporter was enquiring that if a patient reacted to PPSV23, what are the contraindications to receive PREVNAR13. The outcome of the event was unknown. The causality of the event was reported as related to PNEUMOVAX23. Additional information has been requested.
Expired vaccine used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 20-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 08-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication and treatment information was reported. It was reported that the box of vials was received on 14-Oct-2021. It was frozen when it was received and was immediately placed in the clinic vaccine freezer. The vials remained frozen until the date of use and were thawed in the vaccine refrigerator prior to use. The vials remained in the refrigerator between uses and each vial was discarded after the final appointment of the day. Only 1 vial was used per day between the hours of 8:00am to 4:00pm.
Child developed red rash over Varicella injection site - measuring 6 in. long x 6 in. wide - 1 day after receiving vaccine.
Muscle cramps in chest & upper arms. Intense flu-like sxs. Hot & cold.
it is getting worse; headache; nose congestion; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (nose congestion), CONDITION AGGRAVATED (it is getting worse) and HEADACHE (headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot # 007M208) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced NASAL CONGESTION (nose congestion) and HEADACHE (headache). On an unknown date, the patient experienced CONDITION AGGRAVATED (it is getting worse). At the time of the report, NASAL CONGESTION (nose congestion), CONDITION AGGRAVATED (it is getting worse) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.
Patient woke up with pain on his right chest with redness. His physician diagnosis him with celluitis and told him it was possible from the flu vaccine (Afluria).
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. From late February 2016 to 12-MAY-2016, the patients were vaccinated with unspecified doses of improperly stored ROTATEQ immunization series (lot # L027070 with expiration date of 30-APR-2017; dose unknown) orally. The vaccines were exposed at 32 Fahrenheit (F) as lowest for 1395 hours (58 days) as worse case scenario. The temperature excursion was cumulative since late February 2016 per manual recording system. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd flu vax & 3 days later pt exp pain in the shoulder which extended down the arm to below the elbow; 19NOV92 pt reported tenderness to palpation in the rt brachioradialis muscle w/aching @ noc; also soreness in the arm;
after 1st vaccine 5/24 dev dry positional cough, had 2nd vaccine 6/14. comes to the ER 6/15 w persistent dry cough and tachycardia unresolved w fluids. Being admitted for further workup. Neg for PE/Pna, trop neg. ddx pericarditis vs generalized rx to vaccine, also is found to have long-standing vascular congestion/cardiomegaly w thickened GB, low albumin/high bili (4), mild anasarca that's new
Headache, muscle aches and tingling in hands that eve.  Headache the next day.  4 days later became very ill for 1 week with fever for 4 days, sore throat, severe cough, headache and muscle aches.
Infant started having increased temperature on Saturday. On Sunday, at 02:00, it was 104.1F and infant was taken to ER and seen by a doctor. He Rx'd Cefzil 125mg bid X 10 days. No otitis, only pink TM and no other abnormal findings. Temperature today is 101.2F and taken to PMD and stated probably DTAP and to only give Cefzil X 5 days. Mother to consult PMD and get note on what vaccine is ok for next visit. This child was adopted.
Information has been received from a healthcare worker concerning a 77 year old female with hypertension, cholesterol, thyroid disorder, sulfonamide allergy and oral cortisone allergy who on 11-NOV-2008 was vaccinated with PNEUMOVAX 23 (lot # 662100/0742X) 0.5ml, subcutaneously into the right arm. Concomitant therapy included unspecified "thyroid, hypertension and cholesterol medications". On 12-NOV-2008 the patient developed orange size red, swollen, painful area at the site of injection. It was unknown if the patient had ever had PNEUMOVAX 23 prior to this one. There was no laboratory diagnostic studies performed. On approximately 14-NOV-2008, the patient was recovered. The patient sought medical attention by telephone. Additional information is not expected.
on 4/12/2021 found to have severe elevated BP 180/80 range which persisted despite BP medications.  On May 12, 2021 found to have elevated creatinine, potassium and decreased E GFR.   Duplex ultrasound on the left kidney demonstrated renal artery stenosis to 80%+.   After renal parameters were improved with fluids, left kidney artery was stented (X2) with resolution of the high BP.  No clear etiology for stenosis was noted (no plaque, no clot etc)
I had lots of sweating, joint aches, nausea.  I started to feel better by Monday. I went to a gym.  On the previous Friday I bumped my knee.  I had pain in my knee early Tuesday morning and took a tylenol.  IT was better.  When I got up the knee was swollen.  I also developed a rash under the injection site.  I saw a doctor on the advice of the nurse advice line.  He said I also had a rash on the leg with the swollen knee.
severe muscle weakness; felt unwell; she felt dizzy; had a brain fog but gone now; lousy; This is a spontaneous report from a contactable consumer (patient). A 84-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: Unknown) via an unspecified route of administration on 01Jun2021 (at the age of 84 years old) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: Unknown) via an unspecified route of administration on 11May2021 as dose 1, single for COVID-19 immunization. On 01Jun2021, after 40 minutes of receiving the vaccine, patient experienced severe muscle weakness, dizziness, felt lousy and felt unwell. Patient also had a brain fog along with felt dizzy, lousy but gone at time of reporting. Patient wanted to know what she can do to end the side effects sooner because it was already 1 month. She took tylenol and took lots of water to manage the side effects. She did mention that it was better now but it does not go away. She had some health issues and does have muscle weakness periodically. The outcome of the event severe muscle weakness and felt unwell was recovering, she felt dizzy, lousy and had a brain fog recovered on an unspecified date in 2021.  Information on Lot/Batch information has been requested.
Cephalgia, fever, myalgias, T 38.4C. Presented to ED to r/o meningitis on 4/7/06. Diagnosis: viral syndrome. I do not know if Adacel played any role in this event. Reporting for the purpose of adverse SE surveillance (OMIC)
A mother reported that her 12 month old daughter received an injection of Prevnar in April, 2002. Subsequently the child developed a "stomach virus." The mother also reported that the child developed a decrease in appetite and a change in her sleep patterns. The stomach virus has resolved. The reporter did indicate that she did not think the stomach virus was due to Prevnar as she developed the same stomach virus. She does believe
Site: Swelling at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: patient having muscle spasms in forearm shoulder and back since 2 days after 2 covid shot-Medium, Systemic: Joint Pain-Medium, Systemic: Weakness-Severe, Additional Details: patient received covid shot on 12-8-21 . 2 days later she started having muscle spams in shoulder, back and forearm that continue today. She saw her doctor today and he told her to have us do report.
Both legs red and knots at injection sites. Instructed to give Tylenol and use warm compresses.
Patient received the third dose; Insomnia; itching; fever; This is a spontaneous report from a contactable consumer. An adult male patient of an unknown age received third booster dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN); both via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On an unknown date, after the third dose, the patient experienced insomnia, itching and fever. The clinical outcome of the events insomnia, itching and fever was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Fever, vomiting. 5 cm swelling and erythema at injection site, right thigh.
Headache, NauseaVomiting, chills, injection site pain/discomfort Narrative: Employee reports experiencing injection site pain/discomfort, chills, headaches, nausea, and vomiting. BP 106/60 mmHg, temperature 98.3 F. Took Tylenol 650mg at ~12:00pm.